Short Interest in Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Declines By 20.5%

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 5,800 shares, a drop of 20.5% from the March 15th total of 7,300 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 58.0 days.

Santhera Pharmaceuticals Stock Performance

Shares of Santhera Pharmaceuticals stock remained flat at $16.45 during trading hours on Monday. Santhera Pharmaceuticals has a fifty-two week low of $16.00 and a fifty-two week high of $17.01. The business’s 50-day simple moving average is $14.04 and its 200 day simple moving average is $11.71.

About Santhera Pharmaceuticals

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).